The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage

Tonsillectomy Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02228135
• Other study ID #: IRB14-00588
• Status: Completed
• Phase: N/A
• First received: August 27, 2014
• Last updated: July 24, 2017
• Start date: September 2014
• Est. completion date: February 2017

Study information

• Verified date: July 2017
• Source: Nationwide Children's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a retrospective chart review looking at the effect of dexamethasone dosing on post-tonsillectomy hemorrhage.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 9843
• Est. completion date: February 2017
• Est. primary completion date: February 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients undergoing a tonsillectomy

• Patients undergoing an adenotonsillectomy

Exclusion Criteria:

• All patients with a known history of bleeding or clotting disorders, as well as those patients who had presented to Nationwide Children's Hospital main operating room for control of PTH but had their initial tonsillectomy/adenotonsillectomy at an outlying facility will be excluded from the study.

Related Conditions & MeSH terms

• Adenotonsillectomy
• Tonsillectomy

Intervention

Drug:
• Dexamethasone

Locations

Country	Name	City	State
United States	Nationwide Children's Hospital	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Nicole Elsey

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dexamethasone Dosage		once at start of surgery